CD4 T cell-mediated protection from lethal influenza: Perforin and antibody-mediated mechanisms a one-two punch

被引:237
作者
Brown, Deborah M. [1 ]
Dilzer, Allison M. [1 ]
Meents, Dana L. [1 ]
Swain, Susan L. [1 ]
机构
[1] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
关键词
D O I
10.4049/jimmunol.177.5.2888
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanisms whereby CD4 T cells contribute to the protective response against lethal influenza infection remain poorly characterized. To define the role of CD4 cells in protection against a highly pathogenic strain of influenza, virus-specific TCR transgenic CD4 effectors were generated in vitro and transferred into mice given lethal influenza infection. Primed CD4 effectors conferred protection against lethal infection over a broad range of viral dose. The protection mediated by CD4 effectors did not require IFN-gamma or host T cells, but did result in increased anti-influenza Ab titers compared with untreated controls. Further studies indicated that CD4-mediated protection at high doses of influenza required B cells, and that passive transfer of anti-influenza immune serum was therapeutic in B cell-deficient mice, but only when CD4 effectors were present. Primed CD4 cells also acquired perforin (Pfn)-mediated cytolytic activity during effector generation, suggesting a second mechanism used by CD4 cells to confer protection. Pfn-deficient CD4 effectors were less able to promote survival in intact BALB/c mice and were unable to provide protection in B cell-deficient mice, indicating that Ab-independent protection by CD4 effectors requires Pfn. Therefore, CD4 effectors mediate protection to lethal influenza through at least two mechanisms: Pfn-mediated cytotoxicity early in the response promoted survival independently of Ab production, whereas CD4-driven B cell responses resulted in high titer Abs that neutralized remaining virus.
引用
收藏
页码:2888 / 2898
页数:11
相关论文
共 58 条
[1]   Characterization of CD4+ CTLs ex vivo [J].
Appay, V ;
Zaunders, JJ ;
Papagno, L ;
Sutton, J ;
Jaramillo, A ;
Waters, A ;
Easterbrook, P ;
Grey, P ;
Smith, D ;
McMichael, AJ ;
Cooper, DA ;
Rowland-Jones, SL ;
Kelleher, AD .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5954-5958
[2]   THE CTLS KISS OF DEATH [J].
BERKE, G .
CELL, 1995, 81 (01) :9-12
[3]   Fabrication, microstructure and properties of Fe-TiC ceramic-metal composites [J].
Brown, IWM ;
Owers, WR .
CURRENT APPLIED PHYSICS, 2004, 4 (2-4) :171-174
[4]   Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection [J].
Cerwenka, A ;
Morgan, TM ;
Harmsen, AG ;
Dutton, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) :423-434
[5]   A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells [J].
Cunningham, AC ;
Zhang, JG ;
Moy, JV ;
Ali, S ;
Kirby, JA .
IMMUNOLOGY, 1997, 91 (03) :458-463
[6]   Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells [J].
Debbabi, H ;
Ghosh, S ;
Kamath, AB ;
Alt, J ;
deMello, DE ;
Dunsmore, S ;
Behar, SM .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2005, 289 (02) :L274-L279
[7]   Effector CD4(+) and CD8(+) T-cell mechanisms in the control of respiratory virus infections [J].
Doherty, PC ;
Topham, DJ ;
Tripp, RA ;
Cardin, RD ;
Brooks, JW ;
Stevenson, PG .
IMMUNOLOGICAL REVIEWS, 1997, 159 :105-117
[8]   Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes:: either CD4+ or CD8+ T cells can promote survival and recovery after challenge [J].
Epstein, SL ;
Stack, A ;
Misplon, JA ;
Lo, CY ;
Mostowski, H ;
Bennink, J ;
Subbarao, K .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (01) :91-101
[9]  
Epstein SL, 2002, EMERG INFECT DIS, V8, P796
[10]  
Fuller CL, 1999, J IMMUNOL, V162, P6337